Released January 09, 2020 | SUGAR LAND
en
The global Pharma-Bio Industry has 771 active project reports with a kickoff launch during first-quarter 2020. Of the $15.6 billion in potential investment value, North America has the largest share, with 368 projects valued at just over $9 billion. Asia is in the second spot, with $3.2 billion divided among 116 projects.
Click on the graph below.
Click on the graph below.
